ArticleThe Journal of clinical investigation2023

Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant.

Susan E Prockop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.